Serum levels of soluble intercellular adhesion molecule 1 (sICAM-1) as a potential marker of disease activity and remission in patients with chronic hepatitis C

Panminerva Medica

Volumn 39, Issue 4, 1997, Pages 256-262

  Gattoni, A ^a   Romano, C ^a   Cecere, A ^a   Caiazzo, R ^a   De Bellis, A ^a   Bizzarro, A ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

Hepatitis C; Intercellular adhesion molecule 1; Interferon alfa

Indexed keywords

ALANINE AMINOTRANSFERASE; ALPHA2B INTERFERON; BIOLOGICAL MARKER; INTERCELLULAR ADHESION MOLECULE 1;

ADULT; ARTICLE; BLOOD; FEMALE; HEPATITIS C; HUMAN; MALE; MIDDLE AGED; SOLUBILITY;

ADULT; ALANINE TRANSAMINASE; BIOLOGICAL MARKERS; FEMALE; HEPATITIS C, CHRONIC; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; INTERFERON ALFA-2B; MALE; MIDDLE AGED; SOLUBILITY;

EID: 0031300039     PISSN: 00310808     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Staunton DE, Marlin SD, Stratowa C, Dustin ML, Springer TA. Primary structure of intercellular adhesion molecule 1 (ICAM-1) demonstrates interaction between members of the immunoglobulin and integrin supergene families. Cell 1988;52:925-33.
2. Springer TA. Adhesion receptors of the immune system. Nature 1990;346.425-34.
3. Makgoba MW, Sanders ME, Shaw S. The CD2-LFA-3 and LFA-1-ICAM pathways: relevance to T-cell recognition, Immunol Today 1989;10:417-22.
4. Dustin M, Rothlein R, Bhan AK, Dinarello CA, Springer TA. Induction by IL-1 and interferon. tissue distribution, biochemistry and function of a natural adherence molecule (ICAM-1). J Immunol 1986;137:245-54.
5. Rothlein R, Czajkowski M, O'Neill MM, Marlin SD, Mainolfi E, Merluzzi VJ. Induction of intercellular adhesion molecule-1 on primary and continuous cell lines by pro-inflammatory cytokines. J Immunol 1988;141:1665-9.
6. Makgoba MW, Sanders ME, Luce GEG, Gugel EA, Dustin ML, Springer TA et al. Functional evidence that ICAM-1 is a ligand for LFA-1 in cytotoxic T cell recognition. Eur J Immunol 1988; 18:637-40.
7. Van Seveneter GA, Shimizu Y, Horgan KJ, Shaw S. The LFA-1 ligand ICAM-1 provides an important costimulatory signal for T cell receptor-mediated activation of resting human T cells. J Immunol 1990,144:4579-86.
8. Needleman BW. Increased expression of intercellular adhesion molecule 1 on the fibroblasts of scleroderma patients. Arthritis Rheum 1990;33.1847-51.
9. Hale LP, Martin ME, McCollum DE, Nunley JA, Springer TA, Singer KH et al. Immunohistological analysis of the distribution of cell adhesion molecules within the inflammatory synovial microenvironment Arthritis Rheum 1989;32:22-30.
10. Miyazaki A, Mirakian R, Bottazzo GF. Adhesion molecule expression in Graves' thyroid glands: potential relevance of granule membrane protein (GMP-140) and intercellular adhesion molecule 1 (ICAM-1) in the homing and antigen presentation processes. Clin Exp Immunol 1992;89:52-7.
11. Volpes R, Van Den Oord JJ, Desmet VJ. Immunohistochemical study of adhesion molecules in liver inflammation. Hepatology 1990;12:59-65
12. Volpes R, Van Den Oord JJ, Desmet VJ. Hepatic expression of intercellular adhesion molecule-1 (ICAM-1) in viral hepatitis B. Hepatology 1990;12:148-54.
13. Malizia G, Dino O, Pisa R, Caltagirone M, Giannuoli G, Di Marco V et al Expression of leukocyte adhesion molecules in the liver of patients with chronic hepatitis B infection. Gastroenterology 1991;100:749-55.
14. Torii A, Harada A, Nakao A, Nonami T, Ito M, Takagi H. Expression of intercellular adhesion molecule-1 in hepatocellular carcinoma. J Surg Oncol 1993;53:239-42.
15. Garcìa-Monzòn C, Garcìa-Buey L, Garcìa-Sanchez A, Pajares JM, Moreno-Otero R. Down-regulation of intercellular adhesion molecule 1 on hepatocytes in viral chronic hepatitis treated with interferon alfa-2b Gastroenterology 1993;105:462-9.
16. Rothlein R, Mainolfi EA, Czajkowski M, Marlin SD. A form of circulating ICAM-1 in human serum. J Immunol 1991:147:3788-93.
17. Seth R, Raymod FD, Makgoba MW Circulating ICAM-1 isoforms: diasnostic prospects for inflammatory and immune disorders. Lancet 1991;338:83-4.
18. Sfikakis PP, Tesar J, Baraf H, Lipnick R, Klipple G, Tsokos GC. Circulating intercellular adhesion molecule-1 in patients with systemic sclerosis. Clin Immunol Immunopathol 1993;68:88-92
19. Lampeter ER, Kishimoto TK, Rothlein R, Mainolfi EA, Bertrams J, Kolb H et al. Elevated levels of circulating adhesion molecules in IDDM patients and in subjects at risk for IDDM. Diabetes 1992;41:1668-71.
20. Stegeman CA, Cohen Tervaert JW, Huitema MG, De Long PE, Kallemberg CGM. Serum levels of soluble adhesion molecules intercellular adhesion molecule-1. vascular cell adhesion molecule 1 and E-selectin in patients with Wegener's granulomatosis. Arthritis Rheum 1994;37:1228-35.
21. De Bellis A, Bizzarro A, Gattoni A, Romano C, Di Martino S, Sinisi AA et al. Behaviour of soluble intercellular adhesion molecule-1 and endothelial-leukocyte adhesion molecule-1 concentrations in patients with Graves' disease with or without ophthalmopathy and in patients with toxic adenoma. J Clin Endocrinol Metab 1995;80:2118-21.
22. Adams DH, Mainolfi E, Burra P, Neuberger JM, Ayres R, Elias E et al. Detection of circulating intercellular adhesion molecule-1 in chronic liver diseases. Hepatology 1992;16:810-4.
23. Zohrens G, Armbrust T, Pirzer LJ, Meyer zum Buschenfelde KH. Ramadori G. Intercellular adhesion molecule-1 concentration in sera of patients with acute and chronic liver disease: relationship to disease activity and cirrhosis. Hepatology 1993;18:798-802.
24. Thomson AW, Satoh S, Nussler AK, Tamura K, Woo J, Gavaler J, Van Thiel DH. Circulating intercellular adhesion molecule-1 (ICAM-1) in autoimmune liver disease and evidence for the production of ICAM-1 by cytokine-stimulated human hepatocytes. Clin Exp Immunol 1994;95:83-90.
25. Noun-Aria KT, Koskinas J, Tibbs CJ, Portmann BC, Williams R. Serum intercellular adhesion molecule-1 levels in chronic hepatitis C: association with disease activity and response to interferon a. Gut 1995;36:599-603.
26. Imberti L, Cariani E, Bettinardi A, Zonaro A, Albertini A, Primi D. An immunoassay for specific amplified HCV sequences. J Virol Methods 1991;34:233-43.
27. Scheuer PJ. Classification of chronic viral hepatitis: a need for reassessment. J Hepatol 1991;13:372-4.
28. Adams DH, Hubscher SG, Shaw J, Johnson GD, Babbs C, Rothlein R et al. Increased expression of ICAM-1 on bile ducts in primary biliary cirrhosis and primary sclerosing cholangitis. Hepatology 1991;14:426-32.
29. Gearing AJH. Hemingway I, Pigott R, Hughes J, Rees AJ, Cashman SJ. Soluble forms of vascular adhesion molecules, E-selectin, ICAM-1 and VCAM-1: pathological significance. Ann NY Acad Sci 1992;667:324-31.
30. Bruno S, Rossi S, Petroni ML, Villa E, Zuin M, Podda M. Normal aminotransferase concentrations in patients with antibodies to hepatitis C virus. BMJ 1994;308:697.
31. Naito M, Hayashi N, Hagiwara H, Hiramatsu N, Kasahara A, Fusamoto H et al. Serum hepatitis C virus RNA quantity and histological features of hepatitis C virus carriers with persistently normal ALT levels Hepatology 1994;19:871-5.
32. Prieto M, Olaso V, Verdu C, Cordoba J, Gisbert C, Rayon M et al Does the healthy hepatitis C virus carrier state really exist? An analysis using polymerase chain reaction. Hepatology 1995; 22:413-7.
33. Shindo M, Arai K, Sokawa Y, Okuno T. The virological and histological states of anti-hepatitis C virus-positive subjects with normal liver biochemical values. Hepatology 1995;22:418-25.